HomeProductsAnalytical StandardsDrug ImpuritiesCamptothecin ImpurityBelotecan
Chemical structure of CAS 256411-32-2

Belotecan

CAS No.256411-32-2
MDL No.N/A
MFC25H27N3O4
MW433.50
InChI KeyLNHWXBUNXOXMRL-VWLOTQADSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

Belotecan is a pyranoindolizinoquinoline.

CAS No.256411-32-2
Product NameBelotecan

Biological Targets

TOP1

Associated Conditions

lung cancer·neoplasm·small cell lung carcinoma·non-small cell lung carcinoma·ovarian cancer·
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Evaluation of the toxic potentials of a new camptothecin anticancer agent CKD-602 on fertility and early embryonic development in rats.

Regulatory toxicology and pharmacology : RTP • Vol. 45, Issue 3 • 2006
PMID: 16814440DOI: 10.1016/j.yrtph.2006.05.004

Effects of CKD-602, a new camptothecin anticancer agent, on pregnant does and embryo-fetal development in rabbits.

Drug and chemical toxicology • Vol. 28, Issue 1 • 2005
PMID: 15720034DOI: 10.1081/dct-39685

4-Week repeated intravenous dose toxicity study of a new camptothecin anticancer agent CKD-602 in dogs.

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association • Vol. 43, Issue 5 • 2005
PMID: 15778009DOI: 10.1016/j.fct.2004.12.020

Embryotoxic effects of CKD-602, a new camptothecin anticancer agent, in rats.

Reproductive toxicology (Elmsford, N.Y.) • Vol. 20, Issue 1 • 2005
PMID: 15808800DOI: 10.1016/j.reprotox.2005.01.004

Documentation

Similar Products